GIO Therapeutics

GIO Therapeutics stands at the forefront of medical innovation, specialising in the development of G protein-coupled receptor (GPCR)-targeted pharmaceuticals. Recent scientific research has highlighted the crucial role of GPCRs as membrane receptors within the tumour microenvironment where their role significantly impacts intercellular signalling. This discovery has produced a new pool of potential therapeutic targets, which are now becoming accessible thanks to advanced structure-based drug design techniques. Our innovative approach positions us to address complex challenges in oncology and inflammatory diseases. Each member of the GIO team brings a unique set of skills and experiences, all united by a shared passion for drug discovery and a history of building and creating successful companies. At GIO Therapeutics, we believe in the power of collaboration to drive innovation and achieve groundbreaking results in oncology. We welcome like-minded organisation and professionals to get in touch. GIO Therapeutics is a proud venture of Cumulus Oncology.